- Home
- ATXS vs EVTL Comparison
ATXS vs EVTL Comparison
Compare ATXS & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- EVTL
- Stock Information
- Founded
- ATXS 2008
- EVTL 2016
- Country
- ATXS United States
- EVTL United Kingdom
- Employees
- ATXS N/A
- EVTL N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- EVTL Aerospace
- Sector
- ATXS Health Care
- EVTL Industrials
- Exchange
- ATXS Nasdaq
- EVTL Nasdaq
- Market Cap
- ATXS 676.1M
- EVTL 542.9M
- IPO Year
- ATXS 2015
- EVTL N/A
- Fundamental
- Price
- ATXS $12.50
- EVTL $3.93
- Analyst Decision
- ATXS Hold
- EVTL Strong Buy
- Analyst Count
- ATXS 6
- EVTL 8
- Target Price
- ATXS $24.33
- EVTL $11.43
- AVG Volume (30 Days)
- ATXS 936.9K
- EVTL 1.7M
- Earning Date
- ATXS 11-12-2025
- EVTL 08-05-2025
- Dividend Yield
- ATXS N/A
- EVTL N/A
- EPS Growth
- ATXS N/A
- EVTL N/A
- EPS
- ATXS N/A
- EVTL N/A
- Revenue
- ATXS $706,000.00
- EVTL N/A
- Revenue This Year
- ATXS N/A
- EVTL N/A
- Revenue Next Year
- ATXS N/A
- EVTL N/A
- P/E Ratio
- ATXS N/A
- EVTL N/A
- Revenue Growth
- ATXS N/A
- EVTL N/A
- 52 Week Low
- ATXS $3.56
- EVTL $2.76
- 52 Week High
- ATXS $12.72
- EVTL $15.99
- Technical
- Relative Strength Index (RSI)
- ATXS 67.29
- EVTL 34.79
- Support Level
- ATXS $12.31
- EVTL $3.81
- Resistance Level
- ATXS $12.62
- EVTL $4.26
- Average True Range (ATR)
- ATXS 0.23
- EVTL 0.32
- MACD
- ATXS -0.17
- EVTL -0.01
- Stochastic Oscillator
- ATXS 72.73
- EVTL 24.74
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.